AceView: Gene:NUP160, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.

cDNA accession Links to the sequence	Tissue most 5' clones in red	Match mRNA	From bp to bp in mRNA	From bp to bp in accs.	Clone encodes complete protein (with AA variation)	Features	Anomalies detected by AceView	Accession match over (% length)	Base differences relative to genome (% identity)
NM_015231.1		.a	1 to 5383	1 to 5383	exact	RefSeq,		5383/5383 (100 %)	1 diff (100.0 %id)
BC125227	PCR rescued clones	.a	39 to 4581	1 to 4543	T351A	tiling clone,		4543/4543 (100 %)	2 diff (100.0 %id)
BC125228	PCR rescued clones	.a	39 to 4581	1 to 4543	T351A			4543/4543 (100 %)	2 diff (100.0 %id)
DB461429	testis	.a	150 to 641	1 to 492				492/492 (100 %)	2 diff (99.6 %id)
DA724837		.a	152 to 704	2 to 555		capped		554/554 (100 %)	2 diff (99.7 %id)
DA489841	brain	.a	160 to 724	2 to 566		capped		565/565 (100 %)	2 diff (99.7 %id)
DR001567	fetal brain	.a	161 to 909	1 to 749				749/749 (100 %)	6 diff (99.2 %id)
DA461555	tongue, tumor tissue	.a	162 to 718	2 to 558		capped		557/557 (100 %)	0 diff (100 %id)
BX502749	Liver	.a	163 to 486	1 to 324				324/324 (100 %)	29 diff (91.1 %id)
CR987781	T-Lymphocytes	.a	167 to 1094	1 to 928				928/928 (100 %)	3 diff (99.7 %id)
DB082173	testis	.a	169 to 736	2 to 569		capped		568/568 (100 %)	0 diff (100 %id)
DB448587	testis	.a	170 to 589	1 to 419				419/419 (100 %)	18 diff (95.8 %id)
DB442969	testis	.a	171 to 588	1 to 418				418/418 (100 %)	5 diff (98.9 %id)
AL832029	human skeletal muscle	.a	172 to 5381	1 to 5208		available from DKFZ, AAA		5208/5209 (99 %)	12 diff (99.8 %id)
BX500974	Liver	.a	175 to 453	1 to 281				281/281 (100 %)	14 diff (95.1 %id)
AK304308	trachea	.a	176 to 4773	1 to 4598		tiling clone,		4598/4598 (100 %)	2 diff (100.0 %id)
CR977476	T-Lymphocytes	.a	176 to 1018	1 to 847				845/847 (99 %)	8 diff (99.1 %id)
DA798700	brain	.a	177 to 721	2 to 546		capped		545/545 (100 %)	1 diff (99.9 %id)
DB232382	trachea	.a	177 to 765	2 to 590		capped		589/589 (100 %)	1 diff (99.9 %id)
DB062328	testis	.a	180 to 714	2 to 537		capped		536/536 (100 %)	2 diff (99.7 %id)
CN420735	embryonic stem cells, DMSO-treated H9 cellline	.a	181 to 952	1 to 772				772/772 (100 %)	0 diff (100 %id)
CX760383	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	181 to 950	1 to 767			Submitted on the opposite strand	767/768 (99 %)	4 diff (99.5 %id)
DB727745	testis	.a	183 to 833	1 to 644				644/712 (90 %)	24 diff (96.7 %id)
BM475877	eye, retinoblastoma	.a	191 to 1164	1 to 982				982/1020 (96 %)	28 diff (97.3 %id)
CT001922	T-Lymphocytes	.a	197 to 935	1 to 742				742/742 (100 %)	3 diff (99.6 %id)
CD643035	Embryonic Stem cells	.a	212 to 950	12 to 750				739/750 (98 %)	6 diff (99.2 %id)
DW424196	Liver	.a	442 to 714	17 to 289				273/289 (94 %)	6 diff (98.0 %id)
BF344291	brain, glioblastoma with EGFR amplification	.a	536 to 1391	1 to 860				860/867 (99 %)	19 diff (97.9 %id)
DB090436	testis	.a	644 to 1213	2 to 571		capped		570/570 (100 %)	1 diff (99.9 %id)
DA505817	brain	.a	655 to 1233	2 to 580		capped		579/579 (100 %)	0 diff (100 %id)
BE004509	breast_normal	.a	672 to 1079	407 to 1			Submitted on the opposite strand	407/407 (100 %)	5 diff (98.8 %id)
BU431094	lymph	.a	719 to 1178	1 to 460				460/460 (100 %)	5 diff (99.0 %id)
DW418719	Liver	.a	726 to 1132	12 to 418				407/418 (97 %)	6 diff (98.6 %id)
TI_154152909		.a	726 to 1311	80 to 664				585/585 (100 %)	8 diff (98.7 %id)
W27454	eye, retina	.a	735 to 1261	15 to 543				527/584 (90 %)	14 diff (97.7 %id)
DA092944	cerebellum	.a	772 to 1243	2 to 473		capped		472/472 (100 %)	0 diff (100 %id)
AA368157	placenta	.a	943 to 1255	312 to 1				312/312 (100 %)	2 diff (99.4 %id)
DA099998	cerebellum	.a	1010 to 1461	2 to 453		capped		452/452 (100 %)	2 diff (99.6 %id)
BM559192	eye, retinoblastoma	.a	1020 to 1868	1 to 855				855/1034 (82 %)	17 diff (98.4 %id)
BG995429	head_neck	.a	1028 to 1352	1 to 324				324/325 (99 %)	12 diff (96.4 %id)
DW459204	Liver	.a	1060 to 1199	10 to 149				140/149 (93 %)	6 diff (96.0 %id)
AW503584	lymph	.a	1198 to 1620	1 to 423				423/423 (100 %)	4 diff (99.1 %id)
TI_154159522		.a	1204 to 1669	82 to 547				466/467 (99 %)	2 diff (99.6 %id)
DB090505	testis	.a	1230 to 1796	2 to 568		capped		567/567 (100 %)	0 diff (100 %id)
DA720368		.a	1240 to 1697	2 to 459		capped		458/484 (94 %)	1 diff (99.8 %id)
DA738864		.a	1355 to 1899	2 to 546		capped		545/545 (100 %)	1 diff (99.9 %id)
DB087618	testis	.a	1361 to 1910	2 to 551		capped		550/550 (100 %)	2 diff (99.7 %id)
BF091763	testis_normal	.a	1368 to 1743	401 to 24				378/401 (94 %)	2 diff (99.6 %id)
BG980431	colon_normal	.a	1370 to 1568	205 to 10				196/206 (95 %)	1 diff (99.6 %id)
BG393750	embryonal carcinoma, cell line, testis	.a	1375 to 2058	1 to 678				678/678 (100 %)	18 diff (97.4 %id)
CD642956	Embryonic Stem cells	.a	1386 to 2120	12 to 746				735/747 (98 %)	13 diff (98.3 %id)
DN602297	human embryonic stem cells	.a	1406 to 2275	1 to 870				870/870 (100 %)	2 diff (99.8 %id)
CN344617	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.a	1410 to 1924	1 to 515				515/515 (100 %)	1 diff (99.9 %id)
AW501094	lymph	.a	1473 to 1941	1 to 469				469/469 (100 %)	2 diff (99.6 %id)
CF121940	lymph	.a	1473 to 2178	1 to 705				705/705 (100 %)	3 diff (99.6 %id)
TI_154155684		.a	1477 to 1960	80 to 563				484/485 (99 %)	2 diff (99.6 %id)
TI_154181315		.a	1477 to 2306	70 to 898				829/831 (99 %)	8 diff (99.1 %id)
CX784393	human embryonic stem cells	.a	1486 to 2292	1 to 807				807/807 (100 %)	1 diff (99.9 %id)
DB074479	testis	.a	1487 to 2031	2 to 546		capped		545/545 (100 %)	2 diff (99.7 %id)
DA797625	brain	.a	1496 to 2052	2 to 558		capped		557/557 (100 %)	1 diff (99.9 %id)
DA440901	tongue, tumor tissue	.a	1552 to 2091	2 to 541		capped		540/540 (100 %)	1 diff (99.9 %id)
DA458891	tongue, tumor tissue	.a	1636 to 2181	2 to 547		capped		546/546 (100 %)	2 diff (99.7 %id)
DA805775	brain	.a	1761 to 2292	2 to 534		capped		533/533 (100 %)	2 diff (99.7 %id)
ES315913	melanoma cell line	.a	1813 to 2262	504 to 55			Submitted on the opposite strand	450/504 (89 %)	5 diff (99.1 %id)
AU127538		.a	1962 to 2691	2 to 736		capped		735/769 (95 %)	19 diff (97.6 %id)
DA994780	synovial membrane tissue from rheumatioidarthritis	.a	2044 to 2599	2 to 557		capped		556/556 (100 %)	1 diff (99.9 %id)
AU130557		.a	2046 to 2871	2 to 827		capped		826/835 (98 %)	2 diff (99.8 %id)
AU128997		.a	2120 to 2747	2 to 632		capped		631/635 (99 %)	13 diff (98.0 %id)
BF375736	stomach	.a	2125 to 2648	28 to 552				525/552 (95 %)	18 diff (96.8 %id)
BI048093	stomach	.a	2125 to 2545	9 to 429				421/429 (98 %)	6 diff (98.7 %id)
DA123385	cerebellum	.a	2129 to 2610	2 to 484		capped		483/483 (100 %)	2 diff (99.6 %id)
BI047922	stomach	.a	2131 to 2615	16 to 498				483/501 (96 %)	13 diff (97.5 %id)
AU131259		.a	2133 to 2978	12 to 849		capped		838/888 (94 %)	10 diff (98.9 %id)
BI048304	stomach	.a	2140 to 2492	6 to 360				356/399 (89 %)	18 diff (95.5 %id)
BI048288	stomach	.a	2144 to 2441	7 to 305				299/309 (96 %)	12 diff (96.2 %id)
BG897028	cartilage	.a	2151 to 2485	86 to 419				334/351 (95 %)	5 diff (98.6 %id)
BE825406	lung_normal	.a	2176 to 2328	179 to 30				150/182 (82 %)	0 diff (100 %id)
AW389586	stomach	.a	2190 to 2375	1 to 186				186/186 (100 %)	5 diff (97.4 %id)
DA456287	tongue, tumor tissue	.a	2230 to 2794	2 to 566		capped		565/565 (100 %)	0 diff (100 %id)
CD707026	normal nasopharynx	.a	2234 to 2770	24 to 561				538/561 (95 %)	8 diff (98.6 %id)
DB132699	thymus	.a	2317 to 2859	2 to 544		capped		543/543 (100 %)	0 diff (100 %id)
DA498281	brain	.a	2327 to 2882	12 to 568		capped		557/567 (98 %)	7 diff (98.8 %id)
DA754925		.a	2327 to 2855	11 to 539		capped		529/538 (98 %)	6 diff (98.9 %id)
DB072737	testis	.a	2327 to 2840	12 to 529		capped		518/528 (98 %)	8 diff (98.5 %id)
DA555932		.a	2348 to 2921	2 to 577		capped		576/576 (100 %)	2 diff (99.7 %id)
CN344615	embryonic stem cells, cell lines H1, H7, andH9	.a	2364 to 3048	1 to 686				686/686 (100 %)	2 diff (99.8 %id)
DA473147		.a	2374 to 2925	2 to 553		capped		552/552 (100 %)	0 diff (100 %id)
BU902111	leiomyosarcoma, uterus	.a	2473 to 3416	1 to 951				951/1140 (83 %)	12 diff (99.0 %id)
BI333362	cervical carcinoma cell line, cervix	.a	2479 to 3224	1 to 746				748/793 (94 %)	18 diff (97.8 %id)
DB150140	thymus	.a	2493 to 3020	2 to 529		capped		528/528 (100 %)	0 diff (100 %id)
DB208649	trachea	.a	2515 to 3040	2 to 527		capped		526/526 (100 %)	2 diff (99.7 %id)
CB152176	brain	.a	2559 to 3074	1 to 516				516/516 (100 %)	1 diff (99.9 %id)
AA206525		.a	2603 to 3140	1 to 541				541/543 (99 %)	8 diff (98.6 %id)
BU165187	eye, retinoblastoma	.a	2616 to 3496	1 to 889				889/891 (99 %)	14 diff (98.5 %id)
CN344618	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.a	2618 to 3356	12 to 751				740/751 (98 %)	7 diff (99.1 %id)
BQ212585	embryonal carcinoma, cell line, testis	.a	2632 to 3317	1 to 697				695/944 (73 %)	25 diff (97.4 %id)
DA815407		.a	2677 to 3246	2 to 572		capped		571/571 (100 %)	1 diff (99.9 %id)
DA783497	brain	.a	2678 to 3163	2 to 487		capped		486/488 (99 %)	1 diff (99.8 %id)
BX281151	eye, retinoblastoma	.a	2743 to 3219	1 to 477				477/477 (100 %)	0 diff (100 %id)
BM449456	eye, retinoblastoma	.a	2743 to 3708	1 to 968				968/1007 (96 %)	14 diff (98.7 %id)
CX783954	human embryonic stem cells	.a	2785 to 3488	1 to 703				703/703 (100 %)	1 diff (99.9 %id)
BI091492	cervix	.a	2804 to 3560	1 to 753				755/753 (100 %)	6 diff (99.3 %id)
BF813797	colon_ins	.a	2808 to 3417	639 to 35			Submitted on the opposite strand	605/641 (94 %)	12 diff (98.2 %id)
DA719608		.a	2846 to 3415	2 to 571		capped		570/570 (100 %)	0 diff (100 %id)
AW368940	head_neck	.a	2884 to 3175	1 to 292				292/299 (97 %)	2 diff (99.4 %id)
BG504940	embryonal carcinoma, testis	.a	2891 to 3304	1 to 414				414/724 (57 %)	1 diff (99.9 %id)
BG939131	Bone, Hip	.a	2897 to 3543	1 to 647				647/647 (100 %)	3 diff (99.6 %id)
BG779146	adenocarcinoma, Prostate	.a	3027 to 3717	1 to 691				691/701 (98 %)	11 diff (98.5 %id)
CN420739	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.a	3066 to 3852	1 to 787				787/787 (100 %)	0 diff (100 %id)
BE884522	leiomyosarcoma, uterus	.a	3086 to 3680	1 to 604				604/855 (70 %)	17 diff (98.1 %id)
AU124375		.a	3097 to 3832	2 to 740		capped		739/788 (93 %)	7 diff (99.2 %id)
DA647585		.a	3142 to 3953	2 to 812		capped		811/812 (99 %)	2 diff (99.8 %id)
DA552828		.a	3146 to 3710	2 to 567		capped		566/566 (100 %)	1 diff (99.9 %id)
CR997188	T-Lymphocytes	.a	3152 to 4011	1 to 862				862/862 (100 %)	2 diff (99.8 %id)
CX752748	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	3166 to 3854	1 to 689			Submitted on the opposite strand	689/689 (100 %)	0 diff (100 %id)
CD557114	testis	.a	3219 to 3853	45 to 690				646/992 (65 %)	47 diff (95.3 %id)
FN158735	breast carcinoma	.a	3236 to 3332	98 to 1			Submitted on the opposite strand	98/98 (100 %)	2 diff (98.0 %id)
BQ427558	leiomyosarcoma, uterus	.a	3279 to 4145	1 to 867				867/867 (100 %)	4 diff (99.6 %id)
BF335852	colon	.a	3426 to 3738	314 to 1				312/314 (99 %)	8 diff (97.5 %id)
BF214821	bone marrow, from acute myelogenous leukemia	.a	3470 to 4145	1 to 682				682/821 (83 %)	34 diff (95.9 %id)
CN420738	embryonic stem cells, DMSO-treated H9 cellline	.a	3477 to 3951	1 to 475				475/475 (100 %)	3 diff (99.4 %id)
BE779501	eye, retinoblastoma	.a	3484 to 4172	1 to 683				683/932 (73 %)	18 diff (98.1 %id)
DW431173	Liver	.a	3557 to 3815	12 to 270				259/270 (95 %)	6 diff (97.8 %id)
BM542233	melanotic melanoma, skin	.a	3570 to 4486	13 to 941				929/1051 (88 %)	24 diff (97.8 %id)
BE169159	head_neck	.a	3591 to 3800	13 to 227				216/267 (80 %)	17 diff (93.7 %id)
BC008700	Muscle, rhabdomyosarcoma	.a	3679 to 5381	1 to 1703		tiling clone, available from MGC, AAA		1703/1703 (100 %)	0 diff (100 %id)
BE299984	muscle, rhabdomyosarcoma	.a	3698 to 4454	1 to 744		available from MGC,		744/870 (85 %)	15 diff (98.3 %id)
CN420740	embryonic stem cells, cell lines H1, H7, andH9	.a	3751 to 4306	1 to 556				556/557 (99 %)	0 diff (100 %id)
CK430859	eye, lacrimal gland	.a	3807 to 4420	1 to 614				614/614 (100 %)	0 diff (100 %id)
BI258526	cervical carcinoma cell line, cervix	.a	3821 to 4721	1 to 897				897/951 (94 %)	21 diff (97.8 %id)
CR992672	T-Lymphocytes	.a	3902 to 4840	1 to 938				938/938 (100 %)	4 diff (99.6 %id)
CN420737	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.a	3904 to 4467	1 to 564				564/564 (100 %)	2 diff (99.7 %id)
CB119927	Liver	.a	3920 to 4343	1 to 424				424/424 (100 %)	0 diff (100 %id)
EL950826	eyeball	.a	3975 to 4541	1 to 567				567/567 (100 %)	4 diff (99.3 %id)
BG288142	bladder, transitional cell papilloma, cell line	.a	3980 to 4717	1 to 738				738/738 (100 %)	8 diff (99.0 %id)
BG677492	skin, squamous cell carcinoma	.a	3986 to 4880	1 to 893				893/895 (99 %)	17 diff (98.2 %id)
BG109079	Bone, osteosarcoma, cell line	.a	4025 to 4833	1 to 812				812/887 (91 %)	29 diff (96.8 %id)
EH334288		.a	4034 to 4092	1 to 59				59/59 (100 %)	0 diff (100 %id)
BI754892	brain	.a	4067 to 4861	1 to 793				793/793 (100 %)	7 diff (99.2 %id)
TI_57218444		.a	4067 to 4861	31 to 823				793/823 (96 %)	7 diff (99.2 %id)
ES315832	melanoma cell line	.a	4074 to 4471	494 to 92			Submitted on the opposite strand	401/494 (81 %)	8 diff (98.4 %id)
BF208933	bladder, carcinoma, cell line	.a	4127 to 4545	1 to 419				419/420 (99 %)	5 diff (98.9 %id)
BF209165	bone marrow, from chronic myelogenous leukemia	.a	4153 to 4805	1 to 649				649/649 (100 %)	33 diff (95.0 %id)
BG028145	Bone, osteosarcoma, cell line	.a	4179 to 4654	1 to 479				479/922 (51 %)	9 diff (99.1 %id)
BG739873	skin	.a	4183 to 4990	1 to 793				793/794 (99 %)	20 diff (97.5 %id)
BF240526	bone marrow, from acute myelogenous leukemia	.a	4204 to 4829	73 to 718				571/720 (79 %)	12 diff (98.4 %id)
N53299	multiple sclerosis lesions	.a	4205 to 4633	53 to 488				436/488 (89 %)	13 diff (97.4 %id)
BQ224760	embryonal carcinoma, cell line, testis	.a	4255 to 4727	1 to 477				477/1065 (44 %)	18 diff (98.4 %id)
BE813732	breast_normal	.a	4265 to 4603	11 to 346				338/346 (97 %)	13 diff (96.3 %id)
BG485553	lung	.a	4269 to 5081	1 to 821				821/852 (96 %)	37 diff (95.7 %id)
BF968999	adrenal cortex carcinoma, cell line, adrenal gland	.a	4315 to 5131	1 to 815				815/890 (91 %)	27 diff (97.0 %id)
CN420736	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.a	4333 to 4936	1 to 604				604/604 (100 %)	0 diff (100 %id)
BF217268	brain, glioblastoma	.a	4333 to 4983	1 to 641				641/880 (72 %)	21 diff (97.7 %id)
BG874971	breast	.a	4359 to 4600	243 to 1				243/421 (57 %)	6 diff (98.6 %id)
CD511937	Pooled-Skin	.a	4359 to 5008	1 to 654				654/790 (82 %)	7 diff (99.2 %id)
CA943334	Pancreas, Purified pancreatic islet	.a	4383 to 4811	32 to 460				429/460 (93 %)	6 diff (98.7 %id)
BF696658	brain, primitive neuroectoderm	.a	4386 to 5138	1 to 736				736/837 (87 %)	39 diff (95.4 %id)
BG496895	lung, mucoepidermoid carcinoma	.a	4413 to 5140	1 to 723				723/724 (99 %)	11 diff (98.5 %id)
W68807	heart	.a	4415 to 4904	1 to 492		fully sequenced,		492/492 (100 %)	2 diff (99.6 %id)
BU627107	Bone, Enchondroma cell line	.a	4440 to 5135	714 to 19		AAA	Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base)	696/696 (100 %)	0 diff (100 %id)
CA420042	Bone, Human Chondrosarcoma Cell Line	.a	4508 to 5268	775 to 19		AAA		757/757 (100 %)	5 diff (99.4 %id)
DB516195	testis	.a	4543 to 5268	1 to 720			Submitted on the opposite strand	720/720 (100 %)	25 diff (96.6 %id)
CB410461	maxilla, pooled	.a	4549 to 5059	1 to 511		fully sequenced,		511/511 (100 %)	0 diff (100 %id)
CN265359	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.a	4555 to 4873	1 to 318				318/318 (100 %)	8 diff (97.5 %id)
AI114476	Liver	.a	4579 to 5241	1 to 665		AAA		665/665 (100 %)	8 diff (98.8 %id)
CB270202	adipose	.a	4586 to 5131	1 to 547				547/548 (99 %)	3 diff (99.5 %id)
CB853773	lung, Primary Lung Epithelial Cells	.a	4592 to 4871	311 to 32				280/319 (87 %)	0 diff (100 %id)
AW593619	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.a	4623 to 5270	649 to 1				649/666 (97 %)	9 diff (98.7 %id)
TI_149282205		.a	4643 to 5238	727 to 132		AAA		596/1189 (50 %)	38 diff (96.9 %id)
AI690203	carcinoid, lung	.a	4670 to 5199	1 to 530			Submitted on the opposite strand	530/530 (100 %)	1 diff (99.9 %id)
AI681503	carcinoid, lung	.a	4670 to 5203	1 to 534			Submitted on the opposite strand	534/534 (100 %)	0 diff (100 %id)
AU152474		.a	4692 to 5238	548 to 1				548/550 (99 %)	12 diff (97.9 %id)
BY996607		.a	4701 to 5268	622 to 55		AAA	Submitted on the opposite strand	568/568 (100 %)	2 diff (99.7 %id)
DB368325		.a	4710 to 5238	528 to 1				528/528 (100 %)	24 diff (95.5 %id)
AU151196		.a	4720 to 5268	543 to 1				543/543 (100 %)	10 diff (98.2 %id)
CA310046	Bone, Enchondroma cell line	.a	4721 to 5268	566 to 19		AAA		548/548 (100 %)	1 diff (99.9 %id)
AI656261	pooled germ cell tumors	.a	4759 to 5270	512 to 1				512/516 (99 %)	2 diff (99.7 %id)
BQ023248	placenta	.a	4774 to 5238	483 to 19		AAA		465/465 (100 %)	0 diff (100 %id)
AI952719	pooled germ cell tumors	.a	4783 to 5270	488 to 1				488/488 (100 %)	0 diff (100 %id)
N48153	multiple sclerosis lesions	.a	4801 to 5268	472 to 1				472/483 (97 %)	13 diff (97.4 %id)
DB511249	testis	.a	4802 to 5239	1 to 439			Submitted on the opposite strand	439/444 (98 %)	7 diff (98.5 %id)
DB526837	testis	.a	4814 to 5268	1 to 455			Submitted on the opposite strand	455/455 (100 %)	2 diff (99.6 %id)
AI269483	pooled	.a	4817 to 5271	455 to 1				455/455 (100 %)	0 diff (100 %id)
AW665558	pooled	.a	4822 to 5268	447 to 1				447/447 (100 %)	4 diff (99.2 %id)
FN103941	breast carcinoma	.a	4834 to 4929	95 to 1			Submitted on the opposite strand	95/96 (98 %)	1 diff (99.0 %id)
BE535763	cervix	.a	4838 to 5264	1 to 420				420/420 (100 %)	7 diff (98.4 %id)
BF594277	colon, colon tumor, RER+	.a	4850 to 5238	399 to 11		AAA		389/389 (100 %)	3 diff (99.3 %id)
BF513896		.a	4858 to 5268	428 to 18		AAA		411/411 (100 %)	2 diff (99.6 %id)
BI335216	cervical carcinoma cell line, cervix	.a	4859 to 5269	1 to 409				409/428 (95 %)	4 diff (99.1 %id)
AW511789	moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus	.a	4866 to 5271	406 to 1				406/406 (100 %)	0 diff (100 %id)
W68609	heart	.a	4874 to 5240	370 to 1		fully sequenced,		370/370 (100 %)	1 diff (99.8 %id)
DB513710	testis	.a	4880 to 5268	1 to 392			Submitted on the opposite strand	392/392 (100 %)	10 diff (97.5 %id)
AA742226	germinal center B cell	.a	4900 to 5239	365 to 26				340/365 (93 %)	0 diff (100 %id)
BE774705	uterus	.a	4918 to 5111	195 to 1				195/205 (95 %)	7 diff (96.6 %id)
AW271391	Kidney	.a	4921 to 5268	348 to 1				348/348 (100 %)	2 diff (99.5 %id)
BE774834	uterus	.a	4941 to 5124	183 to 2				182/194 (93 %)	0 diff (100 %id)
AW795604	uterus	.a	4950 to 5123	11 to 185				175/185 (94 %)	6 diff (96.8 %id)
D29578		.a	4952 to 5270	1 to 321				321/321 (100 %)	3 diff (99.1 %id)
BQ024601	placenta	.a	4956 to 5268	331 to 19		AAA		313/313 (100 %)	1 diff (99.7 %id)
CN344616	embryonic stem cells, DMSO-treated H9 cellline	.a	4963 to 5235	273 to 1			Submitted on the opposite strand	273/273 (100 %)	0 diff (100 %id)
AI934240	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.a	5020 to 5238	236 to 13		AAA		224/224 (100 %)	9 diff (96.0 %id)
CB410460	maxilla, pooled	.a	5029 to 5268	287 to 48		fully sequenced, AAA		240/240 (100 %)	1 diff (99.6 %id)
BY999802		.a	5117 to 5271	1 to 155			Submitted on the opposite strand	155/155 (100 %)	0 diff (100 %id)
AW051055	serous papillary carcinoma, high grade, 2pooled tumors, uterus	.a	5124 to 5271	151 to 4				148/151 (98 %)	0 diff (100 %id)
BX647634	human skeletal muscle	.b	1 to 5252	1 to 5252	exact	tiling clone, available from DKFZ, AAA	Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base)	5252/5252 (100 %)	4 diff (100.0 %id)
DB237553	trachea	.b	1872 to 2440	2 to 570		capped		569/569 (100 %)	0 diff (100 %id)
AL832813	lymph node	.b	3699 to 5222	1 to 1524		available from DKFZ,		1524/1529 (99 %)	2 diff (99.9 %id)
AA129386	lung, lung carcinoma	.b	4223 to 4780	1 to 558		fully sequenced,		558/558 (100 %)	14 diff (97.5 %id)
BG534279	lung	.b	4514 to 5206	1 to 699				699/702 (99 %)	12 diff (98.3 %id)
BG939132	Bone, Hip	.b	4564 to 5175	619 to 8				612/619 (98 %)	0 diff (100 %id)
AA133292	lung, lung carcinoma	.b	4583 to 4886	1 to 304		fully sequenced,	Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base)	304/304 (100 %)	0 diff (100 %id)
AA129701	lung, lung carcinoma	.b	4583 to 5231	1 to 649				649/649 (100 %)	7 diff (99.0 %id)
BQ016062	lung, Metastatic Chondrosarcoma	.b	4629 to 5220	607 to 16		AAA		592/592 (100 %)	5 diff (99.2 %id)
BU754234	placenta	.b	4642 to 5220	594 to 16		AAA		579/579 (100 %)	3 diff (99.5 %id)
BF055234	pooled	.b	4663 to 5217	555 to 1				555/555 (100 %)	1 diff (99.9 %id)
AI634562	carcinoid, lung	.b	4703 to 5222	521 to 2				520/521 (99 %)	0 diff (100 %id)
CN420734	embryonic stem cells, cell lines H1, H7, andH9	.b	4728 to 5256	573 to 45		AAA	Submitted on the opposite strand	529/531 (99 %)	1 diff (99.9 %id)
BQ027421	mixed	.b	4742 to 5217	495 to 19		AAA		477/477 (100 %)	2 diff (99.6 %id)
AA129323	lung, lung carcinoma	.b	4750 to 5220	473 to 1		fully sequenced,		473/473 (100 %)	4 diff (99.2 %id)
R43961	whole brain	.b	4754 to 5220	488 to 12		AAA		477/479 (99 %)	25 diff (94.8 %id)
BG059812	brain, glioblastoma without EGFR amplification	.b	4766 to 5219	454 to 1				454/454 (100 %)	1 diff (99.8 %id)
D29021		.b	4786 to 5217	1 to 429				429/429 (100 %)	8 diff (98.2 %id)
BQ025803	placenta	.b	4791 to 5220	445 to 16		AAA		430/430 (100 %)	1 diff (99.8 %id)
AI239764	pooled	.b	4803 to 5220	418 to 1				418/418 (100 %)	0 diff (100 %id)
AI678885	poorly differentiated adenocarcinoma withsignet ring cell features, stomach	.b	4803 to 5220	418 to 1				418/418 (100 %)	1 diff (99.8 %id)
AI873730	serous papillary carcinoma, high grade, 2pooled tumors, uterus	.b	4810 to 5220	411 to 1				411/412 (99 %)	4 diff (99.1 %id)
AI538894	poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus	.b	4824 to 5222	400 to 2				399/400 (99 %)	0 diff (100 %id)
AA904475	pooled	.b	4825 to 5220	396 to 1				396/396 (100 %)	0 diff (100 %id)
AA653518		.b	4826 to 5219	394 to 1				394/394 (100 %)	0 diff (100 %id)
AI287295	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.b	4836 to 5226	391 to 1				391/391 (100 %)	0 diff (100 %id)
AA973355	carcinoid, lung	.b	4851 to 5219	369 to 1				369/369 (100 %)	2 diff (99.5 %id)
AA129745	lung, lung carcinoma	.b	4856 to 5238	398 to 21		fully sequenced, AAA	Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base)	378/378 (100 %)	0 diff (100 %id)
AI866872	adenocarcinoma, Pancreas	.b	4858 to 5220	363 to 1				363/363 (100 %)	0 diff (100 %id)
AA757303	pooled	.b	4876 to 5216	341 to 1				341/341 (100 %)	0 diff (100 %id)
AI186074	lung	.b	4879 to 5221	343 to 1				343/343 (100 %)	1 diff (99.8 %id)
AA737777	pooled germ cell tumors	.b	4916 to 5226	311 to 1				311/311 (100 %)	0 diff (100 %id)
AI825401	pooled germ cell tumors	.b	4918 to 5222	308 to 3				306/308 (99 %)	0 diff (100 %id)
CB069595	Pancreas, Purified pancreatic islet	.b	5013 to 5222	218 to 9				210/218 (96 %)	0 diff (100 %id)
DR980001	placenta	.b	5026 to 5217	1 to 191		AAA	Submitted on the opposite strand	191/191 (100 %)	3 diff (98.5 %id)
AA587412	breast	.b	5054 to 5222	175 to 7				169/175 (96 %)	0 diff (100 %id)
DN920557		.b	5072 to 5218	149 to 3				147/149 (98 %)	0 diff (100 %id)
AK302396	testis	.c	1 to 1960	2 to 1961	exact	tiling clone,		1961/1961 (100 %)	1 diff (100.0 %id)
DC399967	testis	.c	1 to 548	2 to 550				550/550 (100 %)	1 diff (99.9 %id)
DC400280	testis	.c	1 to 536	2 to 538				538/538 (100 %)	2 diff (99.7 %id)
DC400065	testis	.c	1128 to 1702	1 to 576				576/576 (100 %)	2 diff (99.7 %id)
AU117488	whole embryo, mainly head	.d	1 to 818	2 to 819		tiling clone, capped		818/818 (100 %)	4 diff (99.6 %id)
DB355312	whole embryo, mainly head	.d	912 to 1438	527 to 1		tiling clone,		527/566 (93 %)	8 diff (98.6 %id)
BQ948277	epidermoid carcinoma, cell line, lung	.e	1 to 865	1 to 875		tiling clone,		875/875 (100 %)	15 diff (98.3 %id)
BF970088	adrenal cortex carcinoma, cell line, adrenal gland	.e	399 to 1212	1 to 815		tiling clone,		815/1112 (73 %)	43 diff (96.2 %id)
DB062015	testis	.f	1 to 560	2 to 562		tiling clone, capped		561/561 (100 %)	1 diff (99.9 %id)
BI836206	pooled pancreas and spleen	.f	429 to 1015	1 to 586		tiling clone,		584/586 (99 %)	5 diff (99.2 %id)
TI_57164916		.f	431 to 1015	35 to 618				583/618 (94 %)	8 diff (98.8 %id)
AW672826	cervix	.f	722 to 1146	1 to 426		tiling clone,		426/426 (100 %)	2 diff (99.6 %id)
CR606216	Placenta Cot 25-normalized	.g	1 to 1481	1 to 1481	exact	tiling clone,		1481/1481 (100 %)	0 diff (100 %id)
BI559779	testis	.g	2 to 646	1 to 647				647/647 (100 %)	16 diff (97.6 %id)
TI_44348039		.g	7 to 646	95 to 736				642/736 (87 %)	15 diff (98.0 %id)
AA355431		.g	10 to 154	1 to 145				145/145 (100 %)	3 diff (98.0 %id)
DA333972	hippocampus	.g	24 to 600	2 to 579		capped		578/578 (100 %)	1 diff (99.9 %id)
BX340453	Placenta Cot 25-normalized	.g	30 to 532	22 to 512		fully sequenced,		491/512 (95 %)	8 diff (98.5 %id)
BF027488	melanotic melanoma, skin	.g	49 to 758	1 to 701		available from MGC,		701/701 (100 %)	15 diff (97.9 %id)
BG478084	melanotic melanoma, skin	.g	50 to 694	1 to 646				646/646 (100 %)	8 diff (98.8 %id)
BC009822	Skin, melanotic melanoma.	.g	51 to 1532	1 to 1482	exact	tiling clone, available from MGC, AAA		1482/1482 (100 %)	0 diff (100 %id)
BE384944	melanotic melanoma, skin	.g	70 to 766	1 to 717				717/721 (99 %)	40 diff (94.5 %id)
AU119509	whole embryo, mainly head	.g	201 to 984	2 to 785		fully sequenced, capped		784/784 (100 %)	4 diff (99.5 %id)
BF695968	brain, primitive neuroectoderm	.g	222 to 897	1 to 674				674/887 (75 %)	47 diff (94.8 %id)
AK026236	human small intestine	.g	229 to 1537	1 to 1309		available from FLJ, AAA		1309/1309 (100 %)	2 diff (99.9 %id)
CV028199	mixed	.g	238 to 806	1 to 569				569/613 (92 %)	1 diff (99.9 %id)
BX340452	Placenta Cot 25-normalized	.g	502 to 1481	981 to 1		fully sequenced,		981/981 (100 %)	13 diff (98.7 %id)
AW390256	stomach	.g	732 to 1394	686 to 26				661/689 (95 %)	0 diff (100 %id)
AI733785	lung, lung carcinoma	.g	929 to 1285	9 to 365				357/365 (97 %)	6 diff (98.4 %id)
DB357932	whole embryo, mainly head	.g	956 to 1532	573 to 1		fully sequenced,		573/573 (100 %)	8 diff (98.7 %id)
AA135971	lung, lung carcinoma	.g	966 to 1294	1 to 331				331/331 (100 %)	2 diff (99.4 %id)
AW969463		.g	972 to 1393	1 to 422				422/422 (100 %)	0 diff (100 %id)
AA502906	colon	.g	1066 to 1321	256 to 1				256/256 (100 %)	0 diff (100 %id)
AA135836	lung, lung carcinoma	.g	1335 to 1537	208 to 6				203/208 (97 %)	0 diff (100 %id)
AA479774	ovarian tumor, ovary	.h	1 to 459	1 to 457		tiling clone,		457/457 (100 %)	2 diff (99.6 %id)
AA477348	ovarian tumor, ovary	.h	614 to 1040	452 to 26		tiling clone, AAA		427/427 (100 %)	0 diff (100 %id)
BE782858	eye, retinoblastoma	.i	1 to 707	4 to 704	exact	tiling clone,		704/836 (84 %)	10 diff (98.9 %id)
DB446163	testis	.j	1 to 356	1 to 356	P108Q E109R E110K E111R I112L ...	tiling clone,		356/419 (84 %)	7 diff (98.4 %id)
BU663147	blood	.k	1 to 571	570 to 1		tiling clone,	Submitted on the opposite strand	570/570 (100 %)	2 diff (99.7 %id)
AV653935	corresponding non cancerous liver tissue	.k	189 to 529	1 to 341		tiling clone,	Submitted on the opposite strand	341/350 (97 %)	1 diff (99.8 %id)
AV718400	corresponding non cancerous liver tissue	.k	1255 to 1733	479 to 1		tiling clone,	Submitted on the opposite strand	479/479 (100 %)	0 diff (100 %id)
BX482536		.l	1 to 634	634 to 1	L7W D8I L9F S10P W11G ...	tiling clone,	Submitted on the opposite strand	634/634 (100 %)	3 diff (99.6 %id)
BX644876		.l	234 to 634	401 to 1		tiling clone,	Submitted on the opposite strand	401/401 (100 %)	1 diff (99.8 %id)
DA544588		.m	1 to 544	2 to 545	I39F	tiling clone, capped		544/544 (100 %)	1 diff (99.9 %id)
BE076449	breast	.n	-11 to 343	4 to 358	A2R A3R A4R G5D	tiling clone,		355/361 (98 %)	8 diff (97.8 %id)
BE697094	colon	.o	1 to 354	25 to 377	P6T L7S S8E Q9P T10N ...	tiling clone,		353/379 (93 %)	9 diff (97.7 %id)
BF229982	colon	.o	1 to 349	353 to 7	Q9P F56C	tiling clone,		347/353 (98 %)	1 diff (99.8 %id)
AA256085	germinal center B cell	.p-u	1 to 428	1 to 428		tiling clone,		428/428 (100 %)	1 diff (99.8 %id)
BU617916	Bone, Subchondral Bone	.p-u	213 to 880	686 to 19		tiling clone, AAA	Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base)	668/668 (100 %)	0 diff (100 %id)
R50025	breast	.p-u	311 to 596	1 to 295		fully sequenced,		295/295 (100 %)	6 diff (98.0 %id)
AA365022	pineal body	.p-u	356 to 591	1 to 236				236/237 (99 %)	1 diff (99.6 %id)
DW413308	Liver	.p-u	400 to 703	17 to 320				304/320 (95 %)	7 diff (97.9 %id)
DW410640	Liver	.p-u	519 to 835	17 to 333				317/333 (95 %)	6 diff (98.2 %id)
R50364	breast	.p-u	566 to 880	325 to 1		fully sequenced,		325/325 (100 %)	8 diff (97.6 %id)
BM041279	Kidney, Wilms' tumor, cell line	.p-u	685 to 1486	1 to 811		tiling clone, fully sequenced,		811/811 (100 %)	62 diff (92.4 %id)
BM041409	Kidney, Wilms' tumor, cell line	.p-u	1456 to 2021	594 to 17	E20*	tiling clone, fully sequenced,		578/594 (97 %)	20 diff (96.7 %id)
DW432156	Liver	.q-u	1 to 257	10 to 266	V2R C3G	tiling clone,		257/266 (96 %)	5 diff (98.2 %id)
BM822907	stomach	.q-u	161 to 523	1 to 363		tiling clone,		363/363 (100 %)	0 diff (100 %id)
BE550283	pooled germ cell tumors	.q-u	187 to 546	359 to 1				359/359 (100 %)	2 diff (99.5 %id)
BE672040	pooled germ cell tumors	.q-u	187 to 546	359 to 1				359/359 (100 %)	1 diff (99.8 %id)
BE825942	lung_normal	.q-u	403 to 755	1 to 348		tiling clone,		348/351 (99 %)	16 diff (95.5 %id)
BQ377965	uterus	.q-u	545 to 847	306 to 4		tiling clone,		303/323 (93 %)	0 diff (100 %id)
BQ377982	uterus	.q-u	545 to 847	306 to 4				303/323 (93 %)	0 diff (100 %id)
BG618748	Liver	.r-u	1 to 710	1 to 712	exact	tiling clone,		712/712 (100 %)	10 diff (98.6 %id)
BX501115	Liver	.s-u	1 to 689	1 to 687	P8Q G9A C10A S11V I12L ...	tiling clone,		687/687 (100 %)	5 diff (99.3 %id)
BX955482		.t-u	1 to 471	1 to 471	exact	tiling clone,		471/471 (100 %)	0 diff (100 %id)
AA359105	lung	.t-u	432 to 635	1 to 204		tiling clone,		204/204 (100 %)	0 diff (100 %id)
BG992025	head_neck	.u	1 to 611	1 to 607	H4A A5C P6T R8T G9R ...	tiling clone,		607/607 (100 %)	48 diff (92.1 %id)
AA626484	lung, lung carcinoma	.u	213 to 629	1 to 417		tiling clone,		417/417 (100 %)	0 diff (100 %id)
DA264230	caudate nucleus	.va	1 to 558	2 to 560	W66V I67D V68C Q69A P70A ...	tiling clone, capped		559/559 (100 %)	1 diff (99.9 %id)
BF790392	muscle (skeletal)	.va	87 to 627	1 to 537	F27L E28S Y29M G30E M31C ...	tiling clone,		537/538 (99 %)	6 diff (98.9 %id)
AI148447		.va	143 to 614	486 to 15	G30V	tiling clone, AAA		472/472 (100 %)	2 diff (99.6 %id)
CN420741	embryonic stem cells, cell lines H1, H7, andH9	.vb	1 to 599	1 to 599	exact	tiling clone,		599/599 (100 %)	0 diff (100 %id)
DW440131	Liver	.vc-u	182 to 413	8 to 239		tiling clone,		232/239 (97 %)	15 diff (93.8 %id)
BX641486		.vd	1 to 558	1 to 558	exact	tiling clone,		558/558 (100 %)	1 diff (99.9 %id)
DW426947	Liver	.ve-u	1 to 264	17 to 280	D30H G38*	tiling clone,		264/280 (94 %)	6 diff (97.9 %id)
BE698573	uterus_tumor	.vf-u	1 to 258	266 to 6	V7G T8Y S9I F10H L11S ...	tiling clone,		261/280 (93 %)	0 diff (100 %id)
BF375189	stomach	Gene NUP160, variant not shown
DA095971	cerebellum	Gene NUP160, variant not shown				capped	Suspected internal deletion, this clone was ignored
CV362919	uterus	Gene NUP160, variant not shown
D83781		Gene NUP160, variant not shown				available from KIAA,	This clone was ignored
BX503655. matches multiple genes		Gene NUP160, variant not shown					This clone was ignored, also hits gene tersnawby
BX503655. matches multiple genes		Gene tersnawby, variant not shown					This clone was ignored, also hits gene tersnawby
BX503656. matches multiple genes		Gene NUP160, variant not shown					This clone was ignored, also hits gene tersnawby
BX503656. matches multiple genes		Gene tersnawby, variant not shown					This clone was ignored, also hits gene tersnawby
BJ990814	hepatoblastoma	Gene NUP160, variant not shown					This clone was ignored
BJ990815	hepatoblastoma	Gene NUP160, variant not shown					This clone was ignored
DB131589	thymus	Gene NUP160, variant not shown				capped
DB344648	thymus	Gene NUP160, variant not shown
TI_149314333		Gene NUP160, variant not shown					This clone was ignored
CB851640	lung, Primary Lung Cystic Fibrosis EpithelialCells	Gene NUP160, variant not shown				AAA	This clone was ignored
DB278776	uterus	Gene NUP160, variant not shown				capped